Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
Diabetes Care|May 7, 2013
A critical analysis of the clinical use of incretin-based therapies: Are the GLP-1 therapies safe?Peter C Butler, Michael Elashoff, Robert Elashoff, et al.
Journal of the Endocrine Society|August 8, 2017
Down Syndrome-Associated Diabetes Is Not Due To a Congenital Deficiency in <i>β</i> CellsAlexandra E Butler, Wendy Sacks, Robert A Rizza, et al.
Nature Clinical Practice. Endocrinology & Metabolism|October 24, 2007
The replication of beta cells in normal physiology, in disease and for therapyPeter C Butler, Juris J Meier, Alexandra E Butler, et al.
Molecular Aspects of Medicine|February 1, 2015
Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetesLeslie S Satin, Peter C Butler, Joon Ha, et al.
Gastroenterology|February 22, 2011
Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapiesMichael Elashoff, Aleksey V Matveyenko, Belinda Gier, et al.
Diabetes|January 26, 2013
β-Cell failure in type 2 diabetes: a case of asking too much of too few?Safia Costes, Ralf Langen, Tatyana Gurlo, et al.
Endocrinology|July 17, 2003
Diazoxide attenuates glucose-induced defects in first-phase insulin release and pulsatile insulin secretion in human isletsSoon H Song, Christopher J Rhodes, Johannes D Veldhuis, et al.
Diabetes|March 8, 2011
Cyclin-dependent kinase 5 promotes pancreatic β-cell survival via Fak-Akt signaling pathwaysMarie Daval, Tatyana Gurlo, Safia Costes, et al.
Pageof 10